The University of Newcastle’s Professor Nicholas Talley is among the world’s leading gastroenterologists who are meeting in Las Vegas this week to share the latest breakthroughs in gastrointestinal research.
As part of the American College of Gastroenterology’s 77th Annual Scientific meeting, Professor Talley revealed findings showing patients with chronic constipation may be at an increased risk of developing colorectal cancer and benign neoplasms.
Professor Talley’s study “Risk of Developing Colorectal Cancer and Benign Neoplasm in Patients with Chronic Constipation” investigated the prevalence and incidence of colorectal cancer and benign neoplasms in 28,854 patients with chronic constipation and 86,562 controls without chronic constipation.
The study revealed that both colorectal cancer (CRC) and benign neoplasms are more prevalent in chronic constipation (CC) patients compared to a control population free from chronic constipation.
Read more about the study’s findings here.
News from the conference has been promoted internationally on sites including Reuters, The Sacramento Bee, News Medical, Istock Analyst, Columbus Business First and Asian Hospital and Health Care Management.
Professor Nicholas Talley is the Pro Vice-Chancellor of the Faculty of Health at the University of Newcastle. Read more about Professor Talley’s work as a leading neurogastroenterologist.
Want to know more about health and medical research at the University?